189 related articles for article (PubMed ID: 20733612)
1. Effect of intermittent fasting on prostate cancer tumor growth in a mouse model.
Thomas JA; Antonelli JA; Lloyd JC; Masko EM; Poulton SH; Phillips TE; Pollak M; Freedland SJ
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):350-5. PubMed ID: 20733612
[TBL] [Abstract][Full Text] [Related]
2. Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice.
Buschemeyer WC; Klink JC; Mavropoulos JC; Poulton SH; Demark-Wahnefried W; Hursting SD; Cohen P; Hwang D; Johnson TL; Freedland SJ
Prostate; 2010 Jul; 70(10):1037-43. PubMed ID: 20166128
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice.
Rogozina OP; Bonorden MJ; Grande JP; Cleary MP
Cancer Prev Res (Phila); 2009 Aug; 2(8):712-9. PubMed ID: 19654106
[TBL] [Abstract][Full Text] [Related]
4. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.
Venkateswaran V; Haddad AQ; Fleshner NE; Fan R; Sugar LM; Nam R; Klotz LH; Pollak M
J Natl Cancer Inst; 2007 Dec; 99(23):1793-800. PubMed ID: 18042933
[TBL] [Abstract][Full Text] [Related]
5. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.
Ngo TH; Barnard RJ; Cohen P; Freedland S; Tran C; deGregorio F; Elshimali YI; Heber D; Aronson WJ
Clin Cancer Res; 2003 Jul; 9(7):2734-43. PubMed ID: 12855654
[TBL] [Abstract][Full Text] [Related]
6. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice.
Cleary MP; Jacobson MK; Phillips FC; Getzin SC; Grande JP; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):836-43. PubMed ID: 12223427
[TBL] [Abstract][Full Text] [Related]
7. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
8. Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice.
Bonorden MJ; Rogozina OP; Kluczny CM; Grossmann ME; Grambsch PL; Grande JP; Perkins S; Lokshin A; Cleary MP
Nutr Cancer; 2009; 61(2):265-75. PubMed ID: 19235043
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
10. Dose effects of modified alternate-day fasting regimens on in vivo cell proliferation and plasma insulin-like growth factor-1 in mice.
Varady KA; Roohk DJ; Hellerstein MK
J Appl Physiol (1985); 2007 Aug; 103(2):547-51. PubMed ID: 17495119
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo.
Liu B; Lee KW; Li H; Ma L; Lin GL; Chandraratna RA; Cohen P
Clin Cancer Res; 2005 Jul; 11(13):4851-6. PubMed ID: 16000583
[TBL] [Abstract][Full Text] [Related]
12. Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice.
Wheatley KE; Williams EA; Smith NC; Dillard A; Park EY; Nunez NP; Hursting SD; Lane MA
Nutr Cancer; 2008; 60(1):61-8. PubMed ID: 18444137
[TBL] [Abstract][Full Text] [Related]
13. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
[TBL] [Abstract][Full Text] [Related]
14. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
[TBL] [Abstract][Full Text] [Related]
15. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
16. Alternate-day fasting reduces global cell proliferation rates independently of dietary fat content in mice.
Varady KA; Roohk DJ; Bruss M; Hellerstein MK
Nutrition; 2009 Apr; 25(4):486-91. PubMed ID: 19084375
[TBL] [Abstract][Full Text] [Related]
17. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse.
Suttie AW; Dinse GE; Nyska A; Moser GJ; Goldsworthy TL; Maronpot RR
Toxicol Pathol; 2005; 33(3):386-97. PubMed ID: 15805078
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
